European Journal of Chemistry 2013, 4(4), 396-401 | doi: https://doi.org/10.5155/eurjchem.4.4.396-401.878 | Get rights and content

Issue cover





  Open Access OPEN ACCESS | Open Access PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

Synthesis, characterization and in vitro biological evaluation of some new diarylsulfonylurea-chalcone hybrids as potential 5-lipoxygenase inhibitors


Bharat Kumar Bugata (1,*) , Satya Venkata Gopala Krishna Kaladhar Dowluru (2) , Vasudeva Rao Avupati (3) , Venkateswara Rao Gavalapu (4) , Divakara Laxman Somayajulu Nori (5) , Sreenu Barla (6)

(1) Department of Biochemistry and Bioinformatics, Gitam University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India
(2) Department of Biochemistry and Bioinformatics, Gitam University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India
(3) Pharmaceutical Chemistry Division, Andhra University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India
(4) Pharmaceutical Chemistry Division, Andhra University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India
(5) Department of Chemistry, Gitam University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India
(6) Department of Biochemistry and Bioinformatics, Gitam University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India
(*) Corresponding Author

Received: 15 Jul 2013 | Revised: 04 Aug 2013 | Accepted: 06 Aug 2013 | Published: 31 Dec 2013 | Issue Date: December 2013

Abstract


A series of some new diarylsulfonylurea-chalcone hybrids (4a-4y) have been synthesized via Claisen-Schmidt condensation reaction by treating 1-(3-acetylphenyl)-3-tosylurea with various aromatic/heteroaromatic aldehydes in the presence of alkali and characterized by FT-IR, 1H NMR, 13C NMR and LC mass spectral analysis. All the synthesized compounds were evaluated for their in vitro 5-Lipoxygenase inhibitory activity using potato 5-lipoxygenase enzyme. Among the tested compounds 4r and 4o exhibited significant inhibitory activity at IC50 values 7.88±0.14 and 11.77±0.21 µg/mL, respectively. This level of activity was found comparable to that of the reference drug Abietic acid (LI01020) with IC50 value 4.34±0.37 µg/mL and it could be a remarkable starting point to develop new lead molecules.

4_4_396_401

Keywords


Chalcone; 5-Lipoxygenase; Diarylsulfonylurea; Abietic acid (LI01020); Claisen-Schmidt condensation; Diarylsulfonylurea-chalcone hybrid

Full Text:

PDF
PDF    Open Access

DOI: 10.5155/eurjchem.4.4.396-401.878

Links for Article


| | | | | | |

| | | | | | |

| | |

Related Articles




Article Metrics

icon graph This Abstract was viewed 1801 times | icon graph PDF Article downloaded 576 times

Funding information


Gitam University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India

Cited by

Crossref database responds too late...

References


[1]. Kenyon, V.; Chorny, I.; Carvajal, W. J.; Holman, T. R.; Jacobson, M.P. J. Med. Chem. 2006, 49, 1356-1363.
http://dx.doi.org/10.1021/jm050639j
PMid:16480270

[2]. Werz, O. Curr. Drug Targets Inflamm. Allergy. 2002, 1, 23-44.
http://dx.doi.org/10.2174/1568010023344959
PMid:14561204

[3]. Babu, M. A.; Shakya, N.; Prathipati, P.; Kaskhedikara, S. G.; Saxena, A. K. Bioorgan. Med. Chem. 2002, 10, 4035-4041.
http://dx.doi.org/10.1016/S0968-0896(02)00313-9

[4]. Zhang, H. B.; Zhang, Y. A.; Wu, G. Z.; Zhou, J. P.; Huang, W. L.; Hu, X. W. Bioorg. Med. Chem. Lett. 2009, 19, 1740-1744.
http://dx.doi.org/10.1016/j.bmcl.2009.01.082
PMid:19216076

[5]. Frezza, M.; Soulere, L.; Reverchon, S.; Guiliani, N.; Jerez, C.; Queneau, Y.; Doutheau, A. Bioorg. Med. Chem. Lett. 2008, 16, 3550-3556.
http://dx.doi.org/10.1016/j.bmc.2008.02.023
PMid:18294853

[6]. Winters, M. P.; Crysler, C.; Subasinghe, N.; Ryan, D.; Leong, L.; Zhao, S.; Donatelli, R.; Yurkow, E.; Mazzulla, M.; Boczon, L.; Manthey, C. L.; Molloy, C.; Raymond, H.; Murray, L.; McAlonan, L.; Tomczuka, B. Bioorg. Med. Chem. Lett. 2008, 18, 1926-1930.
http://dx.doi.org/10.1016/j.bmcl.2008.01.127
PMid:18308567

[7]. Leon, C.; Rodrigues, J.; Dominguez, N. G. D.; Charris, J.; Gut, J.; Rosenthal, P. J.; Dominguez, J. N. Eur. J. Med. Chem. 2007, 42, 735-742.
http://dx.doi.org/10.1016/j.ejmech.2007.01.001
PMid:17321641

[8]. Ameya, A.; Chavan, C.; Nandini, R. P. J. Chin. Chem. Soc. 2007, 54, 771-777.

[9]. Hanson, J.; Dogne, J. M.; Ghiotto, J.; Moray, A. L.; Kinsella, B. T.; Pirotte, B. J. Med. Chem. 2007, 50, 3928-3936.
http://dx.doi.org/10.1021/jm070427h
PMid:17630727

[10]. Lehr, P.; Billich, A.; Wolff, B.; Nussbaumer, P. Bioorg. Med. Chem. Lett. 2005, 15, 1235-1238.
http://dx.doi.org/10.1016/j.bmcl.2004.11.069
PMid:15686949

[11]. Salamon, E.; Mannhold, R.; Weber, H.; Lemoine, H.; Frank, W. J. Med. Chem. 2002, 45, 1086-1089.
http://dx.doi.org/10.1021/jm010999g

[12]. Heitsch, H.; Becker, A. H. R.; Kleemann, W. H.; Wagner, A. Bioorgan. Med. Chem. 1997, 5, 673-678.
http://dx.doi.org/10.1016/S0968-0896(97)00012-6

[13]. Toth, E. J.; Grindey, B. G.; Ehlhardt, J. W.; Ray, E. J.; Boder, G. B.; Bewley, R. J.; Klingerman, K. K.; Gates, B. S.; Rinzel, M. S.; Schultz, R. M.; Weir, L. C.; Worzalla, F. J. J. Med. Chem. 1997, 40, 1018-1025.
http://dx.doi.org/10.1021/jm960673l
PMid:9083492

[14]. Picard, A. J.; Obrien, M. P.; Sliskovic, R. D.; Anderson, K. M.; Bousley, F. R.; Hamelehle, L. K.; Krause, R. B.; Stanfield, L. R. J. Med. Chem. 1996, 39, 1243-1252.
http://dx.doi.org/10.1021/jm9509455
PMid:8632431

[15]. Khelili, S.; Leclerc, G.; Faury, G.; Verdetti, J. Bioorgan. Med. Chem. 1995, 5, 495-503.
http://dx.doi.org/10.1016/0968-0896(95)00040-N

[16]. Lee, C. J. M.; Elberling, A. J.; Nagasawa, T. H. J. Med. Chem. 1992, 35, 3641-3647.
http://dx.doi.org/10.1021/jm00098a007

[17]. Mohamadi, F.; Spees, M. M.; Grindey, B. G. J. Med. Chem. 1992, 35, 3012-3016.
http://dx.doi.org/10.1021/jm00094a013

[18]. Love, B.; Snader, M. K. J. Med. Chem. 1968, 2, 1251-1270.

[19]. Uehling, E. D.; Donaldson, H. K.; Deaton, N. D.; Hyman, E. C.; Sugg, E. E.; Barrett, G. D.; Hughes, G. R.; Reitter, B.; Adkison, K. K.; Lancaster, E. M.; Lee, F.; Hart, R.; Paulik, A. M.; Sherman, W. B.; True, T.; Cowan, C. J. Med. Chem. 2002, 45, 567-583.
http://dx.doi.org/10.1021/jm0101500

[20]. Choi, J. K.; Noh, M. K.; Choi, D. J.; Park, S. J.; Won, S. H.; Kim, R. J.; Kim, S. J.; Yoon, M. Y. B Korean Chem. Soc. 2006, 10, 1697-1700.

[21]. Shuichi, F.; Masanori, I.; Atsutaka, Y.; Makoto, M.; Morihiro, M.; Iichiro, S. J. Biol. Chem. 2005, 24, 23653-23659.

[22]. Dinkova, K. A. T.; Massiah, M. A.; Bozak, R. E.; Hicks, R. J.; Talalay P. P. Natl. Acad. Sci. USA 2001, 98, 3404-3409.
http://dx.doi.org/10.1073/pnas.051632198
PMid:11248091 PMCid:PMC30666

[23]. Nakagawa, G.; Lee, K. Tetrahedron Lett. 2006, 47, 8263-8265.
http://dx.doi.org/10.1016/j.tetlet.2006.09.110

[24]. Narender, T.; Shweta; Gupta S. Bioorg. Med. Chem. Lett. 2004, 14(15), 3913-3916.
http://dx.doi.org/10.1016/j.bmcl.2004.05.071
PMid:15225696

[25]. Nielsen, S. F.; Chen, M.; Theander, T. G.; Kharazmi, A.; Christensen, S. B. Bioorg. Med. Chem. Lett. 1995, 5, 449-452.
http://dx.doi.org/10.1016/0960-894X(95)00053-V

[26]. Wu, J. H.; Wang, X. H.; Lee, K. H. Bioorgan. Med. Chem. 2003, 13, 1813-1815.
http://dx.doi.org/10.1016/S0960-894X(03)00197-5

[27]. Wu, X.; Wilairat, P.; Go, M. Bioorg. Med. Chem. Lett. 2002, 12, 2299-2302.
http://dx.doi.org/10.1016/S0960-894X(02)00430-4

[28]. Phrutivorapongkul, A.; Kirtikaro, K. Chem. Pharm. Bull. 2003, 51(6), 746-748.

[29]. Kumar, S. K.; Hager, E.; Pettit, C.; Gurulingappa, H.; Davidson, N. E.; Khan, S. R. J. Med. Chem. 2003, 46, 2813-2815.
http://dx.doi.org/10.1021/jm030213+
PMid:12825923

[30]. Narender, T.; Khaliq, T.; Shweta, N.; Gupta, S. Bioorgan. Med. Chem. 2005, 13, 6543-6550.
http://dx.doi.org/10.1016/j.bmc.2005.07.005
PMid:16185885

[31]. Nakaido, T.; Ohmoto, T. Chem. Pharm. Bull. 1984, 32(12), 4929-4934.
http://dx.doi.org/10.1248/cpb.32.4929

[32]. Kostanekki, S. T.; Szabranki, W. Ber. Dtsch. Chem. Ges. 1904, 37, 2634-2635.
http://dx.doi.org/10.1002/cber.19040370321

[33]. Jun, N.; Hong, G.; Jun, K. Bioorgan. Med. Chem. 2007, 15(6), 2396-2402.
http://dx.doi.org/10.1016/j.bmc.2007.01.017
PMid:17267225

[34]. Zhao, L. M.; Jin, H. S.; Sun, L. P.; Piao, H. R.; Quan, Z. S. Bioorg. Med. Chem. Lett. 2005, 15(22), 5027-5029.
http://dx.doi.org/10.1016/j.bmcl.2005.08.039
PMid:16169724

[35]. Assia, S.; Kaddour, L.; Mahieddine, M.; Nouara, Z.; Paul, M. Eur. J. Chem. 2011, 2(3), 311-313.
http://dx.doi.org/10.5155/eurjchem.2.3.311-313.414

[36]. Mohammed, R. A.; Mohammed, H. R. K.; Vedula, G. S.; Nasreen, B.; Syed, A.; Yejella, R. P. Eur. J. Chem. 2012, 3(2), 186-190.
http://dx.doi.org/10.5155/eurjchem.3.2.186-190.554

[37]. Mohammed, S. B.; Aly, A. A.; Ashraf, F. W.; Marwa, M. R. Eur. J. Chem. 2013, 4(2), 92-97.
http://dx.doi.org/10.5155/eurjchem.4.2.92-97.615

[38]. Avupati, V. R.; Yejella, R. P.; Guntuku, G.; Gunta, P. Bioorg. Med. Chem. Lett. 2012, 22, 1031-1035.
http://dx.doi.org/10.1016/j.bmcl.2011.11.125
PMid:22200598

[39]. Claisen, L.; Claparede A. Ber. 1881, 14, 2463-2479.

[40]. Sircar, J. C.; Shwender, C. J.; Johnson, E. A. Prostaglandins 1983, 25, 393-396.
http://dx.doi.org/10.1016/0090-6980(83)90042-4

[41]. Reddenna, P.; Whelan, J.; Maddipati, R. K. R. Methods Enzymol. 1990, 187, 268-277.
http://dx.doi.org/10.1016/0076-6879(90)87031-W

[42]. Ulusu, N. N.; Ercil, D.; Sakar, M. K.; Tezcan, E. E. Phytother. Res. 2002, 16, 88-90.
http://dx.doi.org/10.1002/ptr.983
PMid:11807975


How to cite


Bugata, B.; Dowluru, S.; Avupati, V.; Gavalapu, V.; Nori, D.; Barla, S. Eur. J. Chem. 2013, 4(4), 396-401. doi:10.5155/eurjchem.4.4.396-401.878
Bugata, B.; Dowluru, S.; Avupati, V.; Gavalapu, V.; Nori, D.; Barla, S. Synthesis, characterization and in vitro biological evaluation of some new diarylsulfonylurea-chalcone hybrids as potential 5-lipoxygenase inhibitors. Eur. J. Chem. 2013, 4(4), 396-401. doi:10.5155/eurjchem.4.4.396-401.878
Bugata, B., Dowluru, S., Avupati, V., Gavalapu, V., Nori, D., & Barla, S. (2013). Synthesis, characterization and in vitro biological evaluation of some new diarylsulfonylurea-chalcone hybrids as potential 5-lipoxygenase inhibitors. European Journal of Chemistry, 4(4), 396-401. doi:10.5155/eurjchem.4.4.396-401.878
Bugata, Bharat, Satya Venkata Gopala Krishna Kaladhar Dowluru, Vasudeva Rao Avupati, Venkateswara Rao Gavalapu, Divakara Laxman Somayajulu Nori, & Sreenu Barla. "Synthesis, characterization and in vitro biological evaluation of some new diarylsulfonylurea-chalcone hybrids as potential 5-lipoxygenase inhibitors." European Journal of Chemistry [Online], 4.4 (2013): 396-401. Web. 17 Jun. 2021
Bugata, Bharat, Dowluru, Satya, Avupati, Vasudeva, Gavalapu, Venkateswara, Nori, Divakara, AND Barla, Sreenu. "Synthesis, characterization and in vitro biological evaluation of some new diarylsulfonylurea-chalcone hybrids as potential 5-lipoxygenase inhibitors" European Journal of Chemistry [Online], Volume 4 Number 4 (31 December 2013)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item



DOI Link: https://doi.org/10.5155/eurjchem.4.4.396-401.878

CrossRef | Scilit | GrowKudos | Researchgate | Publons | Microsoft | scibey | Scite | Lens | OUCI

WorldCat Paperbuzz Citeas | Dimensions | Semanticscholar | Plumx | Kopernio | Zotero | Mendeley

ZoteroSave to Zotero MendeleySave to Mendeley



European Journal of Chemistry 2013, 4(4), 396-401 | doi: https://doi.org/10.5155/eurjchem.4.4.396-401.878 | Get rights and content

Refbacks

  • There are currently no refbacks.




Copyright (c)





© Copyright 2010 - 2021  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2021 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.